Results 61 to 70 of about 8,522 (72)

PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

Oncogene, 2010
Klas G Wiman
exaly  

APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells

European Journal of Haematology, 2011
Stefan Deneberg, Hareth Nahi, Sören Lehmann   +2 more
exaly  

PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

Cancers, 2017
Ahmad Najem, Sven Saussez, Ahmad Awada
exaly  

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

Cell Death and Disease, 2015
Klas G Wiman
exaly  

An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

Journal of Virology, 2005
Johan Neyts
exaly  

HqMOLYTIC DISEASE OF THE NEWBORN THE FATE OF 246 RHESUS-INCOMPATIBLE PREGNANCIES

Lancet, The, 1957
exaly  

Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models

Archives of Pharmacal Research, 2014
Kiwon Jung
exaly  

Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model

Antiviral Research, 2008
Aysegul Nalca
exaly  

Development of ST-246® for Treatment of Poxvirus Infections

Viruses, 2010
exaly  

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

Proceedings of the National Academy of Sciences of the United States of America, 2010
exaly